Biomedical Sample Clauses

Biomedical. Continued supporting biomedical services at community-based HIV testing services plus (CBHTC+) sites, at home (HBTC+) and resource centers (RC); the latter until Feb 2017 when GOT requested IP to close them • Developed partner notification SOPs and tools and rolled out services at all project sites • Continued meeting and lobbying with the care and treatment implementing partners to exchange data reports on the ART cascade of HIV-infected KVP • Continued conducting internal quality control of HIV rapid tests in all regions together with the district laboratory coordinators who supplied the teams with known samples • Rolled out STI periodic presumptive treatment (PPT) in Dar es Salaam, Iringa, Njombe, and Mbeya • Supported quarterly stakeholder1 supportive supervision visits to CBHTC+, HBTC+ and RC • Supported MOHCDGEC to review STI guidelines, STI training curriculum and M&E tools, and the HTS guidelines • Participated in, and was the secretariat of, the review of the National Guidelines for Comprehensive Package of HIV Interventions for Key and Vulnerable Populations 2014, and provided technical assistance during the workshops on ART-differentiated service delivery models • Provided technical assistance to MOHCDGEC by reviewing the Health Sector HIV/AIDS Strategic Plan III (2012-2017) and contributing to the development of the Health Sector HIV/AIDS Strategic Plan IV (2018-2020). • Regularly participated in the FP technical working group (TWG) and FP training subcommittee technical meeting both chaired by Reproductive, Child Health Section (RCHS) of MOHCDGEC • Rolled out FP training to 18 biomed team and conducted on-the-job training on use of Implanon NXT to 55 biomed providers • Rolled out of focus group discussion on PrEP, CTC Linkage and Partner notification • Intensified supportive supervision to the regions with low performance - i.e., Mbeya, Shinyanga, Tabora, Mtwara, and Singida • Introduced community ART study to R/CHMT and started service delivery in Njombe region (project SOAR/Pop Council); cumulatively enrolled 233 FSW into community ART within the first 38 days of operation, across four councils – reference to Figure 7 below • Drafted HIVST and PrEP SOPs and tools, and participated in the development of the national PrEP protocol 250 200 150 100 50 0 4-Jul-17 5-Jul-17 6-Jul-17 7-Jul-17 8-Jul-17 9-Jul-17 10-Jul-17 11-Jul-17 12-Jul-17 13-Jul-17 14-Jul-17 15-Jul-17 16-Jul-17 17-Jul-17 18-Jul-17 19-Jul-17 20-Jul-17 21-Jul-17 22-Jul-17 23-Jul-17 2...
Sample 1
AutoNDA by SimpleDocs
Biomedical neurobiological, pharmacological and clinical research
Sample 1
Biomedical. VRI Biomedical Limited (ASX Code: VRI) is an Australian biopharmaceutical company specialising in the development and commercialisation of its world leading probiotic technology. In 2004 VRI launched its proTractTM range of gastrointestinal products in Australian pharmacies and has since negotiated distribution/licensing agreements in other countries. For further information contact:- Xx Xxx Xxxxxxx, VRI CEO on 02/9209 4268 VRI BioMedical Ltd is bringing science to wellness by commercialising a range of VRI BioMedical Ltd ACN 084 464 193 ABN 97 084 464 193 Suite G09, 0 Xxxxxxx Xxxxxx, Xxxxxxxxxx Xxxxxxxxxx Xxxx, Xxxxxxxx, Xxxxxx XXX 0000, Xxxxxxxxx Phone: +00 0 0000 0000 Fax: +00 0 0000 0000 products for health maintenance and disease prevention, based on robust scientific and clinical research. VRI BioMedical has developed extensive intellectual property in three platform technologies:
Sample 1
Biomedical. Most worksites visited lacked comprehensive HIV/AIDS related services and commodities including RH and STI kits. Following worksites requested partners, including the government to help deliver quality services to those in need. The assessment showed the imperative to address HTC demands and misconceptions associated with knowing one’s HIV status through HTC campaigns, other IEC activities, and through proper counseling and testing modalities in the worksite clinics as well as referral networks. The need to increase condom access at worksites was also revealed. Establishing linkages with surrounding care and support facilities and awareness creation activities was deemed critical as many of the worksite respondents were not willing to share meals and dorms/rooms with a person they knew had HIV.
Sample 1

Related to Biomedical

  • Cornerstone shall notify the LLC and confirm such advice in writing (i) when the filing of any post-effective amendment to the Registration Statement or supplement to the Prospectus is required, when the same is filed and, in the case of the Registration Statement and any post-effective amendment, when the same becomes effective, (ii) of any request by the Securities and Exchange Commission for any amendment of or supplement to the Registration Statement or the Prospectus or for additional information and (iii) of the entry of any stop order suspending the effectiveness of the Registration Statement or the initiation or threatening of any proceedings for that purpose, and, if such stop order shall be entered, Cornerstone shall use its best efforts promptly to obtain the lifting thereof.

  • Medical There shall be an open enrollment period for medical coverage in each year of this Agreement. An employee may elect no medical coverage during any open enrollment period. An employee who has elected no medical coverage may elect medical coverage during an open enrollment period. No pre-existing condition limitations will apply.

  • Major Medical Program provides benefits after basic coverage is exhausted, and for medical office visits, ambulance care and durable equipment. Notes: Deductible $100 per individual, $300/family Coinsurance 80/20 Stop Loss $2,000 per individual Outpatient Psychiatric Per State Mandate

  • University Any notice may be served upon the University by delivering it, in writing, to the University at the address set forth on the last page of this Agreement, by depositing it in a United States Postal Service deposit box with the postage fully prepaid and with the notice addressed to the University at the aforementioned address, or by sending a facsimile of it to the University facsimile number set forth on the last page of this Agreement.

  • Generelt A. Apple Inc. (“Apple”) giver hermed licenstager licens til at bruge Apples software samt tredjeparters software, dokumentation, grænseflader, indhold, skrifter og evt. data, som følger med denne licens, uanset om de forefindes som ROM (Read Only Memory) eller på andet medie (under et kaldet “Apple- software”) i henhold til betingelserne i denne licensaftale. Apple og/eller Apples licensgivere bevarer ejendomsretten til selve Apple-softwaren og forbeholder sig alle de rettigheder, som ikke udtrykkeligt er givet til licenstager.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Medical Care The Parents must comply with the School Welfare Officer's recommendations which may include a reasonable decision to release the Pupil home or to his / her education guardian when s/he is unwell.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. Respiratory Therapy This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Medical Devices This Article applies when the Goods and/or Services involve UC purchasing or leasing one or more medical devices from Supplier, or when Supplier uses one or more medical devices in providing Goods and/or Services to UC. Medical Device as used herein will have the meaning provided by the U.S. Food and Drug Administration (“FDA”) and means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: (i) recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them; (ii) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (iii) intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. Supplier warrants that prior to UC’s purchase or lease of any Medical Device or Supplier’s use of any Medical Device in providing Goods and/or Services hereunder, Supplier will: (i) perform security testing and validation for each such Goods and/or Services or Medical Device, as applicable; (ii) perform a security scan by an anti-virus scanner, with up-to-date signatures, on any software embedded within any Goods and/or Services or Medical Device, as applicable, in order to verify that the software does not contain any known viruses or malware; (iii) conduct a vulnerability scan encompassing all ports and fuzz testing; and (iv) provide UC with reports for (i) – (iii). Supplier warrants that all security testing performed by Supplier covers all issues noted in the “SANS WE TOP 25” and/or “OWASP Top 10” documentation. Throughout Supplier’s performance of this Agreement, Supplier will provide UC with reasonably up-to-date patches, firmware and security updates for any Medical Device provided to UC, and any other Medical Device used in the course of providing Services, as applicable. All such patches and other security updates will be made available to UC within thirty (30) days of its commercial release or as otherwise recommended by Supplier or Supplier’s sub-supplier, whichever is earlier. Supplier warrants that all software and installation media not specifically required for any Medical Device used by Supplier or Goods and/or Services delivered to UC under this Agreement as well as files, scripts, messaging services and data will be removed from all such Goods and/or Services or Medical Device following installation, and that all hardware ports and drives not required for use or operation of such Goods and/or Services or Medical Device will be disabled at time of installation. In addition, Medical Devices must be configured so that only Supplier-approved applications will run on such Medical Devices. Supplier agrees that UC may take any and all actions that it, in its sole discretion, deems necessary to address, mitigate and/or rectify any real or potential security threat, and that no such action, to the extent such action does not compromise device certification, will impact, limit, reduce or negate Supplier’s warranties or any of Supplier’s other obligations hereunder. Supplier warrants that any Medical Device provided to UC, and any other Medical Device used in the course of providing such Goods and/or Services, meet and comply with all cyber-security guidance and similar standards promulgated by the FDA and any other applicable regulatory body. If the Goods and/or Services entail provision or use of a Medical Device, Supplier will provide UC with a completed Manufacturer Disclosure Statement for Medical Device Security (MDS2) form for each such Medical Device before UC is obligated to purchase or lease such Medical Device or prior to Supplier’s use of such device in its performance of Services. If Supplier provides an MDS2 form to UC concurrently with its provision of Goods and/or Services, UC will have a reasonable period of time to review such MDS2 form, and if the MDS2 form is unacceptable to UC, then UC in its sole discretion may return the Goods or terminate the Agreement with no further obligation to Supplier.

Time is Money Join Law Insider Premium to draft better contracts faster.